Jean-Frederic Viret

Chief Financial Officer, ANESIVA, INC.

Companies

SpyGlass Pharma, Inc.Chief financial officer Feb 5, 2026 to now¹
NGM Biopharmaceuticals (United States)Chief financial officer Nov 8, 2023 to Apr 8, 2024²
Coherus BioSciences (United States)Chief financial officer Nov 6, 2014 to Feb 3, 2021³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

NGM Biopharmaceuticals (United States)0 shares⁴Apr 5, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Apr 5, 2024U 3,038 shares of NGM Biopharmaceuticals (United States)⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARSpyGlass Pharma, Inc., Chief financial officer
2
SEC EDGARNGM Biopharmaceuticals (United States), Chief financial officer
3
SEC EDGARCoherus BioSciences (United States), Chief financial officer
4
SEC EDGARNGM Biopharmaceuticals (United States) shares after the filing of Apr 5, 2024